WASHINGTON — A form of immunotherapy that could get rid of a person's allergy to peanuts is likely within five years, even as the condition appears to grow more and more common, a U.S. expert said on Thursday.
Peanut allergy often appears in the first three years of life, with the allergic reaction to eating peanuts ranging from a minor irritation all the way to a life-threatening, whole-body allergic response called anaphylaxis.
Many children grow out of other food allergies such as milk or eggs, but only about 20 percent lose their peanut allergy.
Dr. Wesley Burks, a food allergy expert at Duke University Medical Center in Durham, North Carolina, wrote in the Lancet medical journal that a solution appears to be on the horizon.
"I think there's some type of immunotherapy that will be available in five years. And the reason I say that is that there are multiple types of studies that are ongoing now," Burks said in a telephone interview.
Read the full Reuters story here.
Latest from Quality Assurance & Food Safety
- FDA, CDC Investigate Salmonella Outbreak Linked to Live It Up Dietary Supplement Powder
- USDA FSIS Announces New Deputy Administrator of Field Operations
- ProVeg Incubator Launches Fast-Track to Impact Program for Alt-Protein Startups
- Kerry Releases 2026 Global Taste Charts
- FDA Shares Australia Certificate Requirements for Bivalve Molluscs and Related Products
- FDA Announces Update from CFIA on Certificate Requirements for Certain Meat, Poultry Products
- NIMA Partners Introduces the Next-Generation NIMA Gluten Sensor
- IFT to Host Community Conversation on Dietary Guidelines for Americans, 2025-2030 Report